{"id":107434,"date":"2024-03-25T20:41:11","date_gmt":"2024-03-26T00:41:11","guid":{"rendered":"https:\/\/med.virginia.edu\/cell-biology\/?p=107434"},"modified":"2026-05-22T17:01:12","modified_gmt":"2026-05-22T21:01:12","slug":"clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction","status":"publish","type":"post","link":"https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/","title":{"rendered":"Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction"},"content":{"rendered":"<p><strong>UVA Author:<\/strong> Nicholas Chavkin<br \/>\n<strong>Citation:<\/strong> Cochran JD, Yura Y, Thel MC, Doviak H, Polizio AH, Arai Y, Arai Y, Horitani K, Park E, Chavkin NW, Kour A, Sano S, Mahajan N, Evans M, Huba M, Naya NM, Sun H, Ban YH, Hirschi KK, Toldo S, Abbate A, Druley TE, Ruberg FL, Maurer MS, Ezekowitz JA, Dyck JRB, Walsh K. Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction. Circulation. 2023 Oct 10;148(15):1165-1178. doi: 10.1161\/CIRCULATIONAHA.123.064170. Epub 2023 Sep 8. PMID: 37681311; PMCID: PMC10575571.<\/p>\n<p><strong>DOI:<\/strong> <a>https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.123.064170<\/a><br \/>\n<strong>Pub-Med Number<\/strong>: 37681311<\/p>\n<hr \/>\n<p>Background: Clonal hematopoiesis (CH), which results from an array of nonmalignant driver gene mutations, can lead to altered immune cell function and chronic disease, and has been associated with worse outcomes in patients with heart failure (HF) with reduced ejection fraction. However, the role of CH in the prognosis of HF with preserved ejection fraction (HFpEF) has been understudied. This study aimed to characterize CH in patients with HFpEF and elucidate its causal role in a murine model.<\/p>\n<p>Methods: Using a panel of 20 candidate CH driver genes and a variant allele fraction cutoff of 0.5%, ultradeep error-corrected sequencing identified CH in a cohort of 81 patients with HFpEF (mean age, 71\u00b16 years; ejection fraction, 63\u00b15%) and 36 controls without a diagnosis of HFpEF (mean age, 74\u00b17 years; ejection fraction, 61.5\u00b18%). CH was also evaluated in a replication cohort of 59 individuals with HFpEF.<\/p>\n<p>Results: Compared with controls, there was an enrichment of TET2-mediated CH in the HFpEF patient cohort (12% versus 0%, respectively; P=0.02). In the HFpEF cohort, patients with CH exhibited exacerbated diastolic dysfunction in terms of E\/e&#8217; (14.9 versus 11.7, respectively; P=0.0096) and E\/A (1.69 versus 0.89, respectively; P=0.0206) compared with those without CH. The association of CH with exacerbated diastolic dysfunction was corroborated in a validation cohort of individuals with HFpEF. In accordance, patients with HFpEF, an age \u226570 years, and CH exhibited worse prognosis in terms of 5-year cardiovascular-related hospitalization rate (hazard ratio, 5.06; P=0.042) compared with patients with HFpEF and an age \u226570 years without CH. To investigate the causal role of CH in HFpEF, nonconditioned mice underwent adoptive transfer with Tet2-wild-type or Tet2-deficient bone marrow and were subsequently subjected to a high-fat diet\/L-NAME (N\u03c9-nitro-l-arginine methyl ester) combination treatment to induce features of HFpEF. This model of Tet2-CH exacerbated cardiac hypertrophy by heart weight\/tibia length and cardiomyocyte size, diastolic dysfunction by E\/e&#8217; and left ventricular end-diastolic pressure, and cardiac fibrosis compared with the Tet2-wild-type condition.<\/p>\n<p>Conclusions: CH is associated with worse heart function and prognosis in patients with HFpEF, and a murine experimental model of Tet2-mediated CH displays greater features of HFpEF.<\/p>\n<p>Keywords: biomarkers; clonal hematopoiesis; heart failure; prognosis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>UVA Author: Nicholas Chavkin Citation: Cochran JD, Yura Y, Thel MC, Doviak H, Polizio AH, Arai Y, Arai Y, Horitani K, Park E, Chavkin NW, Kour A, Sano S, Mahajan N, Evans M, Huba M, Naya NM, Sun H, Ban YH, Hirschi KK, Toldo S, Abbate A, Druley TE, Ruberg FL, Maurer MS, Ezekowitz JA, [&hellip;]<\/p>\n","protected":false},"author":1740,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13],"tags":[22],"class_list":["post-107434","post","type-post","status-publish","format-standard","hentry","category-featured-publications","tag-intranet"],"acf":false,"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction - Department of Cell Biology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction - Department of Cell Biology\" \/>\n<meta property=\"og:description\" content=\"UVA Author: Nicholas Chavkin Citation: Cochran JD, Yura Y, Thel MC, Doviak H, Polizio AH, Arai Y, Arai Y, Horitani K, Park E, Chavkin NW, Kour A, Sano S, Mahajan N, Evans M, Huba M, Naya NM, Sun H, Ban YH, Hirschi KK, Toldo S, Abbate A, Druley TE, Ruberg FL, Maurer MS, Ezekowitz JA, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Cell Biology\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-26T00:41:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-22T21:01:12+00:00\" \/>\n<meta name=\"author\" content=\"zkr7e@virginia.edu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"zkr7e@virginia.edu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/2024\\\/03\\\/25\\\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/2024\\\/03\\\/25\\\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\\\/\"},\"author\":{\"name\":\"zkr7e@virginia.edu\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/#\\\/schema\\\/person\\\/b4929a1d4683383a392718e12166cd7f\"},\"headline\":\"Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction\",\"datePublished\":\"2024-03-26T00:41:11+00:00\",\"dateModified\":\"2026-05-22T21:01:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/2024\\\/03\\\/25\\\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\\\/\"},\"wordCount\":451,\"keywords\":[\"Intranet\"],\"articleSection\":[\"Featured Publications\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/2024\\\/03\\\/25\\\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\\\/\",\"url\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/2024\\\/03\\\/25\\\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\\\/\",\"name\":\"Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction - Department of Cell Biology\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/#website\"},\"datePublished\":\"2024-03-26T00:41:11+00:00\",\"dateModified\":\"2026-05-22T21:01:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/#\\\/schema\\\/person\\\/b4929a1d4683383a392718e12166cd7f\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/2024\\\/03\\\/25\\\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/2024\\\/03\\\/25\\\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/2024\\\/03\\\/25\\\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/#website\",\"url\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/\",\"name\":\"Department of Cell Biology\",\"description\":\"University of Virginia School of Medicine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/#\\\/schema\\\/person\\\/b4929a1d4683383a392718e12166cd7f\",\"name\":\"zkr7e@virginia.edu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eb05928a9c10d0bc86fc859e223e3e9cd7a535837367cf67c524db2a42f795d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eb05928a9c10d0bc86fc859e223e3e9cd7a535837367cf67c524db2a42f795d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eb05928a9c10d0bc86fc859e223e3e9cd7a535837367cf67c524db2a42f795d0?s=96&d=mm&r=g\",\"caption\":\"zkr7e@virginia.edu\"},\"url\":\"https:\\\/\\\/med.virginia.edu\\\/cell-biology\\\/author\\\/zkr7evirginia-edu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction - Department of Cell Biology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/","og_locale":"en_US","og_type":"article","og_title":"Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction - Department of Cell Biology","og_description":"UVA Author: Nicholas Chavkin Citation: Cochran JD, Yura Y, Thel MC, Doviak H, Polizio AH, Arai Y, Arai Y, Horitani K, Park E, Chavkin NW, Kour A, Sano S, Mahajan N, Evans M, Huba M, Naya NM, Sun H, Ban YH, Hirschi KK, Toldo S, Abbate A, Druley TE, Ruberg FL, Maurer MS, Ezekowitz JA, [&hellip;]","og_url":"https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/","og_site_name":"Department of Cell Biology","article_published_time":"2024-03-26T00:41:11+00:00","article_modified_time":"2026-05-22T21:01:12+00:00","author":"zkr7e@virginia.edu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"zkr7e@virginia.edu","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/#article","isPartOf":{"@id":"https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/"},"author":{"name":"zkr7e@virginia.edu","@id":"https:\/\/med.virginia.edu\/cell-biology\/#\/schema\/person\/b4929a1d4683383a392718e12166cd7f"},"headline":"Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction","datePublished":"2024-03-26T00:41:11+00:00","dateModified":"2026-05-22T21:01:12+00:00","mainEntityOfPage":{"@id":"https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/"},"wordCount":451,"keywords":["Intranet"],"articleSection":["Featured Publications"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/","url":"https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/","name":"Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction - Department of Cell Biology","isPartOf":{"@id":"https:\/\/med.virginia.edu\/cell-biology\/#website"},"datePublished":"2024-03-26T00:41:11+00:00","dateModified":"2026-05-22T21:01:12+00:00","author":{"@id":"https:\/\/med.virginia.edu\/cell-biology\/#\/schema\/person\/b4929a1d4683383a392718e12166cd7f"},"breadcrumb":{"@id":"https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/med.virginia.edu\/cell-biology\/2024\/03\/25\/clonal-hematopoiesis-in-clinical-and-experimental-heart-failure-with-preserved-ejection-fraction\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/med.virginia.edu\/cell-biology\/"},{"@type":"ListItem","position":2,"name":"Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction"}]},{"@type":"WebSite","@id":"https:\/\/med.virginia.edu\/cell-biology\/#website","url":"https:\/\/med.virginia.edu\/cell-biology\/","name":"Department of Cell Biology","description":"University of Virginia School of Medicine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/med.virginia.edu\/cell-biology\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/med.virginia.edu\/cell-biology\/#\/schema\/person\/b4929a1d4683383a392718e12166cd7f","name":"zkr7e@virginia.edu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/eb05928a9c10d0bc86fc859e223e3e9cd7a535837367cf67c524db2a42f795d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/eb05928a9c10d0bc86fc859e223e3e9cd7a535837367cf67c524db2a42f795d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/eb05928a9c10d0bc86fc859e223e3e9cd7a535837367cf67c524db2a42f795d0?s=96&d=mm&r=g","caption":"zkr7e@virginia.edu"},"url":"https:\/\/med.virginia.edu\/cell-biology\/author\/zkr7evirginia-edu\/"}]}},"_links":{"self":[{"href":"https:\/\/med.virginia.edu\/cell-biology\/wp-json\/wp\/v2\/posts\/107434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/med.virginia.edu\/cell-biology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/med.virginia.edu\/cell-biology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/med.virginia.edu\/cell-biology\/wp-json\/wp\/v2\/users\/1740"}],"replies":[{"embeddable":true,"href":"https:\/\/med.virginia.edu\/cell-biology\/wp-json\/wp\/v2\/comments?post=107434"}],"version-history":[{"count":1,"href":"https:\/\/med.virginia.edu\/cell-biology\/wp-json\/wp\/v2\/posts\/107434\/revisions"}],"predecessor-version":[{"id":107519,"href":"https:\/\/med.virginia.edu\/cell-biology\/wp-json\/wp\/v2\/posts\/107434\/revisions\/107519"}],"wp:attachment":[{"href":"https:\/\/med.virginia.edu\/cell-biology\/wp-json\/wp\/v2\/media?parent=107434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/med.virginia.edu\/cell-biology\/wp-json\/wp\/v2\/categories?post=107434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/med.virginia.edu\/cell-biology\/wp-json\/wp\/v2\/tags?post=107434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}